Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1089 blog entries.

September 2024

JMI Develops World’s First Artificial Intelligence Driven Oral Cancer Database

2024-09-04T08:31:58+00:00

A significant advancement in the field of Artificial Intelligence (AI) & digital pathology has emerged from the research team at Multidisciplinary Centre for Advanced Research & Studies (MCARS), Jamia Millia Islamia (JMI), who have developed a groundbreaking dataset designed to enhance the accuracy and efficiency of diagnosing oral submucous fibrosis (OSMF) and oral squamous cell carcinoma (OSCC).

JMI Develops World’s First Artificial Intelligence Driven Oral Cancer Database2024-09-04T08:31:58+00:00

Case Of The Month | September 2024 | Case of B Cell Lymphoma in an 8-Year-Old Entire Male Border Collie

2025-07-29T11:11:09+00:00

An 8-year-old entire male border collie was presented with enlarged peripheral lymph nodes. No other history was supplied. FNAs from the left submandibular, right prescapular and right popliteal lymph nodes were sent for cytological examination.

Case Of The Month | September 2024 | Case of B Cell Lymphoma in an 8-Year-Old Entire Male Border Collie2025-07-29T11:11:09+00:00

August 2024

FUJIFILM Europe Healthcare IT Exhibiting at European Congress of Pathology

2024-08-30T13:51:22+00:00

FUJIFILM Europe Heathcare IT will be attending this year’s European Congress of Pathology (ECP), taking place in Florence, Italy, from the 7th to the 11th of September. The Fujifilm team will be showcasing our SYNAPSE range with a focus on the SYNAPSE(R) Pathology™ software, the global leading solution in Digital Pathology.

FUJIFILM Europe Healthcare IT Exhibiting at European Congress of Pathology2024-08-30T13:51:22+00:00

PathAI’s AISightⓇ Dx Image Management System is CE Marked for Primary Diagnosis

2024-08-28T13:35:06+00:00

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that its AISightⓇ Dx Image Management System (IMS) is In Vitro Diagnostic Regulation (IVDR) certified for use in primary diagnosis. The CE mark paves the way for the company's expansion in the European diagnostic pathology market, enhancing pathologists' interpretations and driving efficiencies and quality improvements within anatomic pathology laboratories.

PathAI’s AISightⓇ Dx Image Management System is CE Marked for Primary Diagnosis2024-08-28T13:35:06+00:00

Indica Labs and Paige Forge Strategic Partnership to Expand Integrated AI for Anatomic Pathology Labs

2024-08-27T15:48:57+00:00

Indica Labs, a leading provider of computational pathology software and Paige, a leader in next-generation AI technology have formed a non-exclusive partnership aimed at integrating Paige's Diagnostic AI models into Indica's robust Anatomic Pathology workflow management software, HALO AP®. This will include Paige's pan-cancer AI application developed using Paige's foundation model technology. The collaboration allows for best-of-breed AI-enabled workflows designed to improve laboratory efficiency, diagnostic quality, and patient outcomes.

Indica Labs and Paige Forge Strategic Partnership to Expand Integrated AI for Anatomic Pathology Labs2024-08-27T15:48:57+00:00

WSK Medical and IMP Diagnostics Receive €1,2 million Eurostars Grant to Develop AI Solution for Automated Analysis of Colorectal Cancer Samples

2024-08-26T08:03:39+00:00

WSK Medical (Amsterdam, the Netherlands), a leading Artificial Intelligence (AI) software solutions provider for oncology care, and IMP Diagnostics (Porto, Portugal), a private molecular and anatomical pathology laboratory, are proud to announce that they have been awarded a prestigious €1,2 million Eurostars grant to support their joint project. The project aims to develop a cutting-edge AI solution [...]

WSK Medical and IMP Diagnostics Receive €1,2 million Eurostars Grant to Develop AI Solution for Automated Analysis of Colorectal Cancer Samples2024-08-26T08:03:39+00:00

OmniScreen by Paige: An AI Tool that Simultaneously Screens 505 Genes for Comprehensive Cancer Diagnosis and More Personalized Treatments

2024-08-23T13:53:20+00:00

Paige, a leader in next-generation AI technology, announces the launch of OmniScreen, a pioneering AI-driven biomarker module capable of evaluating over 505 genes and detecting 1,228 molecular biomarkers from routine H&E-stained digital pathology slides. Built on Paige’s second-generation foundation model, trained on an unprecedented three million slides, this breakthrough represents a major leap forward in the accuracy, speed, and cost-effectiveness of cancer diagnosis and treatment selection.

OmniScreen by Paige: An AI Tool that Simultaneously Screens 505 Genes for Comprehensive Cancer Diagnosis and More Personalized Treatments2024-08-23T13:53:20+00:00

Meet Aiforia at the European Congress of Pathology 2024

2024-08-21T15:59:59+00:00

Aiforia‘s team will attend the European Congress of Pathology in Florence on September 7–11, 2024. Are you ready to hear how AI-assisted image analysis can increase efficiency, precision, and consistency in the pathology workflow?

Meet Aiforia at the European Congress of Pathology 20242024-08-21T15:59:59+00:00

Paige Appoints New Leadership to Further Drive Innovation, Bring Artificial General Intelligence to Pathology, and Expand Access to AI Applications

2024-08-16T14:30:13+00:00

Paige, a leader in next-generation AI technology, today announced a strategic shift to further advance the role and impact of AI in cancer care. This initiative includes leveraging its AI technology to bring Artificial General Intelligence (AGI) to pathology and oncology, as well as transitioning its diagnostic AI applications from being exclusive to the Paige Platform to a standalone solution compatible with other digital pathology platforms.

Paige Appoints New Leadership to Further Drive Innovation, Bring Artificial General Intelligence to Pathology, and Expand Access to AI Applications2024-08-16T14:30:13+00:00
Go to Top